David W. Lam

2.8k total citations
24 papers, 903 citations indexed

About

David W. Lam is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, David W. Lam has authored 24 papers receiving a total of 903 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Surgery and 6 papers in Genetics. Recurrent topics in David W. Lam's work include Diabetes Treatment and Management (10 papers), Diabetes Management and Research (9 papers) and Diabetes and associated disorders (5 papers). David W. Lam is often cited by papers focused on Diabetes Treatment and Management (10 papers), Diabetes Management and Research (9 papers) and Diabetes and associated disorders (5 papers). David W. Lam collaborates with scholars based in United States, Spain and Canada. David W. Lam's co-authors include Derek LeRoith, Tauseef Ali, Mary Beth Humphrey, Michael S. Bronze, Carol J. Levy, Bruce A. Buckingham, Camilla Levister, Ronald Brazg, Anna Chang and Gregory P. Forlenza and has published in prestigious journals such as Blood, Diabetes Care and Diabetes.

In The Last Decade

David W. Lam

23 papers receiving 878 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David W. Lam United States	14	410	296	269	147	145	24	903
Régis Radermecker Belgium	16	623 1.5×	351 1.2×	313 1.2×	58 0.4×	104 0.7×	69	1.0k
Sadishkumar Kamalanathan India	17	359 0.9×	195 0.7×	70 0.3×	129 0.9×	136 0.9×	116	964
Alessandro Rizzi Italy	19	341 0.8×	247 0.8×	82 0.3×	124 0.8×	150 1.0×	65	1.2k
Hongmei Zhang China	12	148 0.4×	163 0.6×	204 0.8×	94 0.6×	160 1.1×	45	1.3k
Elena Grineva Russia	17	220 0.5×	141 0.5×	102 0.4×	90 0.6×	136 0.9×	104	787
Ruth M Ayling United Kingdom	16	122 0.3×	193 0.7×	199 0.7×	132 0.9×	158 1.1×	46	765
Mala Dharmalingam India	19	631 1.5×	227 0.8×	137 0.5×	230 1.6×	180 1.2×	85	1.1k
Pasi I. Nevalainen Finland	12	176 0.4×	545 1.8×	80 0.3×	66 0.4×	127 0.9×	38	912
Mayank Patel United States	14	464 1.1×	326 1.1×	44 0.2×	93 0.6×	217 1.5×	41	1.0k
Mohammad Shafi Kuchay India	15	809 2.0×	353 1.2×	212 0.8×	910 6.2×	259 1.8×	53	1.6k

Countries citing papers authored by David W. Lam

Since Specialization

Citations

This map shows the geographic impact of David W. Lam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David W. Lam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David W. Lam more than expected).

Fields of papers citing papers by David W. Lam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David W. Lam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David W. Lam. The network helps show where David W. Lam may publish in the future.

Co-authorship network of co-authors of David W. Lam

This figure shows the co-authorship network connecting the top 25 collaborators of David W. Lam. A scholar is included among the top collaborators of David W. Lam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David W. Lam. David W. Lam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Requena-Ibáñez, Juan Antonio, M. Urooj Zafar, Ginés Escolar, et al.. (2025). Rationale and Design of the SOTA-THROMBOSIS Trial (ATRU-VI): Antithrombotic Activities of Sotagliflozin Compared With Empagliflozin. Journal of Cardiovascular Pharmacology. 86(5). 458–462. 1 indexed citations

Viola, Helena M., et al.. (2025). Real-World Cost Implications of American Association for the Study of Liver Diseases/American Gastroenterological Association Metabolic Dysfunction-associated Steatotic Liver Disease Guidance for Patients With Diabetes, and Factors Associated With Advanced Fibrosis. Clinical Gastroenterology and Hepatology. 24(2). 554–556. 1 indexed citations

Lam, David W., Stephanie Wang, Nidhi Naik, et al.. (2024). A Real-World Precision Medicine Program Including the KidneyIntelX Test Effectively Changes Management Decisions and Outcomes for Patients With Early-Stage Diabetic Kidney Disease. Journal of Primary Care & Community Health. 15. 4277843597–4277843597. 5 indexed citations

Rodríguez‐Capitán, Jorge, Juan Antonio Requena-Ibáñez, Carlos G. Santos‐Gallego, et al.. (2023). Rationale and Design of the SOTA-P-CARDIA Trial (ATRU-V): Sotagliflozin in HFpEF Patients Without Diabetes. Cardiovascular Drugs and Therapy. 39(1). 155–164. 15 indexed citations

Ogyaadu, Selassie, et al.. (2023). A Novel Algorithm for the Management of Inpatient COVID-19 Glucocorticoid-Induced Hyperglycemia. Clinical Diabetes. 41(3). 378–385.

Lam, David W., Girish N. Nadkarni, Gohar Mosoyan, et al.. (2022). Clinical Utility of KidneyIntelX in Early Stages of Diabetic Kidney Disease in the CANVAS Trial. American Journal of Nephrology. 53(1). 21–31. 17 indexed citations

Ekhlaspour, Laya, Dan Raghinaru, Gregory P. Forlenza, et al.. (2022). Outcomes in Pump- and CGM-Baseline Use Subgroups in the International Diabetes Closed-Loop Trial. Journal of Diabetes Science and Technology. 17(4). 935–942. 3 indexed citations

Galindo, Rodolfo J., Francisco J. Pasquel, Priyathama Vellanki, et al.. (2021). Degludec hospital trial: A randomized controlled trial comparing insulin degludec U100 and glargine U100 for the inpatient management of patients with type 2 diabetes. Diabetes Obesity and Metabolism. 24(1). 42–49. 13 indexed citations

Anderson, Stacey M., Lisa Norlander, Grenye O’Malley, et al.. (2021). Impact of a Novel Diabetes Support System on a Cohort of Individuals With Type 1 Diabetes Treated With Multiple Daily Injections: A Multicenter Randomized Study. Diabetes Care. 45(1). 186–193. 26 indexed citations

10.

Lam, David W. & Aisha Shaikh. (2021). Real-Life Prescribing of SGLT2 Inhibitors: How to Handle the Other Medications, Including Glucose-Lowering Drugs and Diuretics. Kidney360. 2(4). 742–746. 16 indexed citations

11.

Christiansen, Mark, Timothy S. Bailey, Leslie J. Klaff, et al.. (2019). Abstract #300 Evaluation of the Accuracy of an Implantable CGM System with an Updated Glucose Calculation Algorithm. Endocrine Practice. 25. 125–125. 1 indexed citations

12.

Forlenza, Gregory P., Faye Cameron, Trang T. Ly, et al.. (2018). Fully Closed-Loop Multiple Model Probabilistic Predictive Controller Artificial Pancreas Performance in Adolescents and Adults in a Supervised Hotel Setting. Diabetes Technology & Therapeutics. 20(5). 335–343. 59 indexed citations

13.

Christiansen, Mark P., Leslie J. Klaff, Ronald Brazg, et al.. (2018). A Prospective Multicenter Evaluation of the Accuracy of a Novel Implanted Continuous Glucose Sensor: PRECISE II. Diabetes Technology & Therapeutics. 20(3). 197–206. 105 indexed citations

14.

O’Malley, Grenye, Selassie Ogyaadu, David W. Lam, et al.. (2018). Trends in Insulin Pen Priming. Diabetes. 67(Supplement_1). 1 indexed citations

15.

Cameron, Faye, Trang T. Ly, Bruce A. Buckingham, et al.. (2017). Closed-Loop Control Without Meal Announcement in Type 1 Diabetes. Diabetes Technology & Therapeutics. 19(9). 527–532. 75 indexed citations

16.

Greco, Giampaolo, Katherine Kirkwood, Annetine C. Gelijns, Alan J. Moskowitz, & David W. Lam. (2017). Diabetes Is Associated With Reduced Stress Hyperlactatemia in Cardiac Surgery. Diabetes Care. 41(3). 469–477. 14 indexed citations

17.

Zafar, M. Urooj, Donald A. Smith, Usman Baber, et al.. (2017). Impact of Timing on the Functional Recovery Achieved With Platelet Supplementation After Treatment With Ticagrelor. Circulation Cardiovascular Interventions. 10(8). 29 indexed citations

18.

Lam, David W. & Derek LeRoith. (2012). The worldwide diabetes epidemic. Current Opinion in Endocrinology Diabetes and Obesity. 19(2). 93–96. 260 indexed citations

19.

Ali, Tauseef, David W. Lam, Michael S. Bronze, & Mary Beth Humphrey. (2009). Osteoporosis in Inflammatory Bowel Disease. The American Journal of Medicine. 122(7). 599–604. 210 indexed citations

20.

Flanagan, Peter R., David W. Lam, D Banerjee, & L. S. Valberg. (1989). Ferritin release by mononuclear cells in hereditary hemochromatosis.. PubMed. 113(2). 145–50. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact